Compare CVS Health Corp (CVS) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Xcel Energy Inc — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Xcel Energy Inc trades at $77.66 (market cap $48.02B). The key difference: CVS Health Corp is far larger — about 2.5× Xcel Energy Inc's market cap, and Xcel Energy Inc pays the higher dividend (3.08%). Which is the better fit depends on your goals.
| CVS | XEL | |
|---|---|---|
Market Cap | $122.36B | $48.02B |
Sector | Health | Utilities |
52-Week High | $110.60 | $83.91 |
52-Week Low | $65.51 | $71.75 |
Enterprise Value | $184.71B | $86.33B |
Dividend Yield | 2.78% | 3.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Xcel Energy (XEL) trades at $78.07, up 1.43% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $0.93 per share, beating estimates, driven by infrastructure investment recovery. Revenue for 2025 was $14.67B with a net income margin of 15.28%, while the balance sheet shows rising assets and liabilities, with a debt-to-asset ratio of 41.57% in 2024. Recent news highlights community investment and board additions.
The outlook for XEL is supported by a $60 billion capital plan targeting 11% annual rate base growth, but regulatory pushback and affordability concerns pose risks. Analyst consensus is bullish with a $93.80 price target, implying 20% upside, though technical indicators suggest near-term caution. Earnings growth and utility demand trends remain key catalysts for investor returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
